Omada Health, Inc. OMDA
Set alert
18.60 USD +0.75 +4.19%
As of Nov 3, 11:31 AM ET
17.92 Day range 18.64
10.28 52-week range 25.61
- YTD
- +17.86%
- 1 year
- -27.55%
- Open
- 17.92
- Prev close
- 17.85
- Mkt cap
- 1.14B
- Vol
- 97.92K
- Avg vol
- 1.32M
- EPS
- 0.24
- P/E
- 77.54
- Div yield
- 0.00%
More statistics
- Low
- 17.92
- High
- 18.64
- Forward P/E
- 32.10
- Beta
- 0.00
- Short ratio
- 5.58
- Inst. own
- 88.30%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 20.75
- 200-d avg
- 17.68
- 1y target
- 28.17
Analyst view
Consensus: buy
Buy
Price target (mean) 28.17 +51.4% upside
Now 18.60
- Target (low)
- 22.00
- Target (mean)
- 28.17
- Target (high)
- 35.00
Ratings (0m) 12 10 buy · 2 hold · 0 sell
- Strong buy5
- Buy5
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 12
- 1 month ago 12
- 2 months ago 12
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.0981 | 0.08 – 0.121 | 0.0298 | +229.2% | 85.64M | +25.9% | 5 |
| Next quarter | 0.10982 | 0.09 – 0.13 | 0.16199 | -32.2% | 87.02M | +14.7% | 5 |
| Current year | 0.436 | 0.38 – 0.481 | 0.15489 | +181.5% | 338.70M | +30.2% | 5 |
| Next year | 0.55614 | 0.39 – 0.658 | 0.436 | +27.6% | 407.80M | +20.4% | 5 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 28, 2026 | Barclays | Maintained | Overweight | Overweight |
| Oct 14, 2026 | Freedom Capital Markets | Maintained | Buy | Buy |
| Sep 14, 2026 | Freedom Capital Markets | Maintained | Buy | Buy |
| Sep 11, 2026 | Barclays | Maintained | Overweight | Overweight |
| Sep 11, 2026 | Needham | Reiterated | Buy | Buy |
| Sep 11, 2026 | BTIG | Reiterated | Buy | Buy |
| Aug 14, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Aug 14, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Aug 12, 2026 | Baird | Maintained | Neutral | Neutral |
| Aug 10, 2026 | BTIG | Maintained | Buy | Buy |
| Aug 3, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jul 21, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Jul 20, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Jul 17, 2026 | BTIG | Initiated | — | Buy |
| Jun 22, 2026 | Morgan Stanley | Reiterated | Overweight | Overweight |
| May 8, 2026 | Barclays | Maintained | Overweight | Overweight |
| May 8, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| May 8, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| May 8, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| May 8, 2026 | Needham | Reiterated | Buy | Buy |
| Apr 14, 2026 | Citizens | Initiated | — | Market Outperform |
| Apr 9, 2026 | Goldman Sachs | Maintained | Buy | Buy |
| Apr 8, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Mar 12, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Mar 6, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Mar 6, 2026 | BMO Capital | Maintained | Outperform | Outperform |
| Mar 6, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Mar 6, 2026 | Barclays | Maintained | Overweight | Overweight |
| Mar 3, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jan 22, 2026 | Needham | Reiterated | Buy | Buy |